NOS3 and metabolic syndrome: Our results show the potential of in vivo liver MRI and 1H‐MRS to noninvasively diagnose and stage the progression of NAFLD and to monitor treatment response in an eNOS−/− murine model that represents the classic NAFLD phenotype associated with metabolic syndrome.